AKL RESEARCH & DEVELOPMENT LIMITED
Significant control: Nicholas John Larkins (significant control), David Keith Miles (significant control) and 1 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Akl Research & Development Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Akl Research & Development Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
AKL RESEARCH & DEVELOPMENT LIMITED is an active private limited company (company number 08699350) incorporated on 20 September 2013, registered in Manchester. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £302k and cash of £11k, with 5 employees on average. Net assets fell 81% on the prior period (£1.58m). Across the last 3 periods on record the net-asset trend is falling.
By net assets it sits in the top quarter of 138 comparable companies in Manchester (median £436, upper quartile £124k).
Ownership and control
- Dr Nicholas John Larkins
- has significant influence or control
- Mr David Keith Miles
- has significant influence or control
- Mr David Richard Sharples
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 20 September 201313 yrs ago
- Next accounts due
- 30 September 2027in 341 days
- Confirmation statement due
- 4 October 2027in 345 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £302k | £11k | £370k | — | — | — | 5 |
| 31 December 2024 | £1.58m | £1.29m | £304k | — | — | — | 5 |
| 31 December 2023 | £2.98m | £2.18m | £852k | — | — | — | 5 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £302,104 at 31 December 2025
- Net assets down 25% or more on the prior period-80.8% vs prior period
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 20 September 2013
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 345 days
- Next accounts duein 341 days
- Accounts period endNet assets £302k · small accounts
- Accounts period endNet assets £1.58m · small accounts
- Accounts period endNet assets £2.98m · small accounts
- Incorporated
Similar companies in Manchester
- PCR MAX LIMITEDAltrincham · inc. Sept 2013
- ALDERLEY ANALYTICAL LTDMacclesfield · inc. Aug 2013
- INSECT RESEARCH SYSTEMS LTDNewton Le Willows · inc. Jul 2013
- SCOPE INTERNATIONAL (UK) LIMITEDBolton · inc. Apr 2013
- LCC THERAPEUTICS LTD.Warrington · inc. Feb 2014
- N2 PHARMACEUTICALS LTDBolton · inc. Apr 2013
All companies incorporated on 20 September 2013 · in Sept 2013.
Reminders for AKL RESEARCH & DEVELOPMENT LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.